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Abstract A new daunorubicin has been synthesized and struc-
turally characterized. The interaction of native calf thymus
DNA (ctDNA) with 3′-azido-daunorubicin thiosemicarbazone
(ADNRT) was investigated under simulated physiological con-
ditions by multi-spectroscopic techniques, viscometric mea-
surements and molecular modeling study. It concluded that
ADNRT could intercalate into the base pairs of ctDNA, and
the fluorescence quenching by ctDNA was static quenching
type. Thermodynamic parameters calculated suggested that the
binding of ADNRT to ctDNAwas mainly driven by hydropho-
bic interactions. The relative viscosity of ctDNA increased with
the addition of ADNRT, which confirmed the intercalation
mode. Furthermore, molecular modeling studies corroborate
the above experimental results.
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Introduction
As we all know, nucleic acid is the primary intracellular target
of antitumor drugs, owing to small molecules interaction with
DNA and then damaging the formation of DNA in cancer cells
[1]. Thus, the investigation of small molecules binding to DNA
is of current general interest and importance in rational design
of more powerful and selective anticancer pharmaceuticals and
their effectiveness depend on the mode and affinity of the
binding [2].
Daunorubicin, one of the most widely used anthracyclines,
is used for the clinical treatment of a broad range of human
malignancies [3]. Like other intercalating agents, daunorubi-
cin is considered to interfere with the function of topoisomer-
ase II, a nuclear enzyme which can regulate the DNA topol-
ogy [4]. In spite that a great deal of work has been done [5],
the mechanism by which these molecules mediate their rela-
tively selective antitumor effects is not yet clear. What’s more,
severe side effects limited the clinical use of daunorubicin,
such as cardiotoxicity, myelosuppression and drug resistance
[6]. Many efforts have been made to modify the structure of
anthracyclines to generate analogs for the sake of reducing the
side effects and reversing multidrug resistance. In our previ-
ous works, a lead compound derived from daunorubicin, 3′-
azido-3′-deamino daunorubicin (ADNR), was synthesized
and its bioactivities and the binding to human serum albumin
or DNA were also investigated [7–9]. This lead compound
exhibited potent anticancer activity in both drug-sensitive
(K562) and drug-resistant leukemia cells (K562/Dox), with a
25-fold lower drug resistance index than daunorubicin.
Based on the special bioactivities of ADNR and thiose-
micarbazones [10–13], in this paper, we designed and synthe-
sized a hybrid of ADNR with thiosemicabzone, 3′-azido-
daunorubicin thiosemicarbazone (ADNRT, inset of Fig. 1),
and systematically investigated its interaction with calf thy-
mus DNA (ctDNA) in combination with multi-spectroscopic,
viscometric techniques and molecular modeling under simu-
lated physiological conditions (pH 7.4). The characteristics in
spectroscopy measurements revealed that ADNRT could bind
to ctDNA through intercalation binding modes. The results
obtained from the viscosity experiments and molecular
modeling validated those conclusions. This work provides
valuable information on the binding behavior of daunorubicin
with DNA and should be helpful for designing the alternative
or even more active daunorubicin.
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The preparation procedure for ADNRT: A drop of acetic acid
was added to the mixture of ADNR (27.7 mg, 0.05 mmol) and
thiosemicarbazide monohydrochloride (19.1 mg,0.15 mmol)
in methanol (3 mL) and the mixture was stirred overnight.
TLC showed the reaction was completed. The solvent was
removed, then the residue was diluted with saturated aqueous
Na2CO3 solution and extracted with CH2Cl2 (5 mL) for three
times. The combined extractions were dried by Na2SO4 and
concentrated. The crude product was purified on a column of
silica gel to get the pure product ADNRT as a yellow solid
(29.1mg, 93%). HRMS (M+H)+ (ESI) calcd for C28H31N6O9S
627.1867, found 627.1860. 1H NMR (400 MHz, DMSO-
d6):13.99 (1H, s), 13.21 (1H, s), 10.08 (1H, s), 8.22 (1H, s),
7.87–7.80 (2H, m), 7.57 (1H, d, J=8.0 Hz), 7.24 (1H, s), 5.31
(1H, d, J=4.0 Hz), 5.17 (2H, m), 4.84 (1H, s), 4.10–4.05
(1H, m), 3.94 (1H, s), 3.60 (1H, d, J =4.0 Hz), 3.49–
3.46 (1H, m), 3.13 (1H, d, J =16.0 Hz), 2.83 (1H, d, J =
20.0 Hz), 2.31 (1H, dd, J =4.0 Hz, J =12.0 Hz), 2.15 (1H, dd,
J =4.0 Hz, J =12.0 Hz), 2.00 (3H, s), 1.69 (1H, dd, J =4.0 Hz,
J =12.0 Hz), 1.14 (3H, d, J =8.0 Hz); 13C NMR (100 MHz,
DMSO-d6):186.3, 186.1, 179.1, 160.7, 156.2, 155.5, 154.2,
136.1, 135.7, 135.5, 134.5, 119.8, 119.5, 118.9, 110.5, 99.6,
72.2, 70.7, 69.0, 67.0, 56.5, 55.6, 38.1, 33.4, 28.1, 16.9, 11.9.
The stock solution (8.3×10−5 mol L−1) of ADNRT
(synthesized) was prepared. An appropriate amount of solid
ctDNA (Sigma-Aldrich Chemicals Company, USA) without
further purification was dissolved into the doubly distilled
water and stored at 4 °C. The ratio of the absorbance at
260 nm and 280 nm>1.8, indicated that ctDNA was
sufficiently free from protein [14]. The concentration of
DNA (4.6×10−4 mol L−1) in stock solution used for binding
experiments was determined by the absorption intensity at
260 nm using a molar absorption coefficient value of
6600 L mol−1 cm−1 [15]. All regents were of analytical grade,
and doubly distilled water was used throughout.
Methods
Absorption Measurements
The UV absorption spectra were recorded on a TU-1810
spectrophotometer (Puxi Analytic Instrument Ltd., Beijing,
China) by adding the increments of ctDNA stock solution into
a fixed concentration of ADNRT. The solutions were allowed
to incubate for 10 min before the absorption spectra were
recorded. The ctDNA solutions of corresponding concentra-
tions were measured as reference solutions. All UV measure-
ments were carried out in Tris–HCl buffer (pH 7.4) at room
temperature.
Fluorescence Measurements
All fluorescence measurements were performed on a Varian
Cary Eclipse spectrofluorimeter (VARIAN, USA) equipped
with a SHP DC-0515 thermostatic bath (Shanghai Hengping
Sciences Instrument Co. Ltd., Shanghai, China), and a quartz
cuvette of 1 cm path length. 2.0 mL pH 7.4 of Tris–HCl buffer
solution, certain volume of drug and vary volume of ctDNA
solution were transferred to a 10 mL volumetric flask, and the
mixed solution was diluted to the final volume with doubly
distilled water. These solutions were allowed to stand for
8 min to equilibrate. The fluorescence emission spectra were
measured at 295, 303 and 310 K in the wavelength range of
520–750 nm with an excitation wavelength at 254 nm.
Viscosity Measurements
Viscosity measurements were carried out by Ubbelodhe vis-
cometer, which was immersed in a thermostat water-bath at a
constant temperature at 25±0.1 °C. Various concentrations of
ADNRTwere then added into the viscometer to give a certain
r (r =[drug]/[DNA]) value while the ctDNA concentration
was constant. The flow time of the samples were repeatedly
measured by a digital stopwatch with an accuracy of ±0.20 s
after thermal equilibrium was achieved (15 min). The result of
each point was the average of at least three readings. The data
were presented as η /η0 versus r, where η and η0 are the
viscosity of ctDNA in the presence and absence of ADNRT.
Viscosity values were calculated from observing the flow time
Fig. 1 Fluorescence spectra of ADNRT in the presence of ctDNA (inset:
structure of ADNRT). CctDNA=0, 4.6, 9.2, 13.8, 18.4, 23.0 and 27.6×
10−6 mol · L−1 for curves 1–7; CADNRT=3.3×10
−6 mol · L−1
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of ctDNA containing solutions (t >180 s) and corrected by
buffer solution (t0), using η =(t - t0)/t0 [16].
Molecular Docking
The rigid molecular docking study was performed by Sybyl
6.9 software. The crystal structure of the B-DNA was
extracted from the structure having Protein Data Bank identi-
fier 425D. The structure of ADNRT was sketched and mini-
mized with the help of the Trops force field using Gasteiger–
Marsili charges. The macromolecule file was prepared for
docking by adding polar hydrogen atoms and Gasteiger
charges. After DNA was enclosed in the grid defined with
0.375 Å spacing, the grid map was calculated using the FlexX
program. Visualization of the docked pose was done by using
PyMol.
Results and Discussion
Interaction Between ADNRT and ctDNA
Spectral Characteristics of ADNRT Binding to ctDNA
It is known that the intrinsic fluorescence of DNA is of little
practical use [17], whereas the titled molecule displays lumi-
nescent property (λ ex/λ em=254/590 nm). Hence, the fluores-
cence emission spectra of ADNRT in the absence and pres-
ence of ctDNA were studied. As shown in Fig. 1, with the
increasing amounts of ctDNA, the fluorescence intensity of
ADNRT decreased without apparent shift of maximum fluo-
rescence emission wavelength, which indicated the binding of
ADNRT to ctDNA indeed existed.
The formation of ADNRT-ctDNA complex was further con-
firmed by UV absorption spectra (Fig. 2). The UV absorption
spectra of ADNRTshowed an intense absorption band, assigned
to the π-π* transition of the anthraquinone chromophore
[18]. It was apparent that as the concentration of ctDNA
increased, the absorption peak at 230 nm decreased significant-
ly with slight red shift (2 nm). These spectral changes sug-
gested that ADNRTwas likely to interact with ctDNA through
some binding modes. Moreover, it is necessary to judge the
binding mode of ADNRTwith ctDNA by other methods.
The Quenching Mechanism of Fluorescence of ADNRT
by ctDNA
The mechanisms of fluorescence quenching are usually clas-
sified as dynamic quenching and static quenching, which can
Fig. 2 Absorption spectra of ADNRT in presence of ctDNA at different
concentrations (versus corresponding concentration of ctDNA) at pH=7.4;
Conditions:CADNRT=8.3×10
−7 mol · L−1, from 1 to 7:CctDNA=0, 4.6, 9.2,
13.8, 18.4, 23.0 and 27.6×10−6 mol · L−1
Fig. 3 a Stern-Volmer curves of
ctDNA quenching the
fluorescence of ADNRT. b
Double logarithmic curves of
ctDNA quenching the
fluorescence of ADNRT
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be distinguished by examination of the temperature on the
Stern-Volmer equation (Eq. (1)):
F0
F
¼ 1þ Kqτ0 DNA½  ¼ 1þ KSV DNA½  ð1Þ
where F0 and F are the fluorescence intensities in the absence
and presence of ctDNA, respectively, Kq is the quenching rate
constant of biomolecular, τ0 is the average lifetime of the
fluorophore and KSV is the Stern-Volmer quenching constant
which can measure the fluorescence quenching efficiency.
It was assumed that the interaction of ADNRTwith ctDNA
proceeded via a dynamic quenching. The KSV value was
obtained from the slope of the F0/F versus [DNA] linear plot
(Fig. 3a), and the values of KSV and Kq at the three tempera-
tures (295, 303 and 310 K) are listed in Table 1. As can be
seen, the values of KSV decreased with the increasing temper-
ature, indicating that the fluorescence quenching of ADNRT
by ctDNAwas static [19].
Binding Constant and Binding Sites
For a static quenching interaction, it is often assumed that the
binding capability of DNA at each binding site is equal [20].
The binding constantK and the number of binding site n can be




¼ logK þ nlog DNA½  ð2Þ
The values ofK and n were obtained from the intercept and
slope of the plot of log[(F0-F)/F ] versus log[DNA] (Fig. 3b).
The corresponding results at different temperatures are sum-
marized in Table 2. The values of n approximately equal to 1
indicated that there was just a single binding site between
ctDNA and ADNRT. The increasing trend of K with
temperature indicated that the capacity of ADNRT binding
to DNAwas enhanced with the temperature rising [21].
Thermodynamic Parameters and Nature of Binding Forces
The acting forces between a small molecule and macromole-
cule mainly include hydrogen bonds, van der Waals force,
electrostatic force and hydrophobic interaction force. To fur-
ther characterize the interaction forces, the thermodynamic
parameters which are the main evidence to determine the
binding mode were analyzed. If the enthalpy change (ΔH)
does not vary significantly within the range of temperature,
the thermodynamic parametersΔH andΔS can be estimated






The free energy change (ΔG ) was estimated from the
Gibbs’ equation [23]:
ΔG ¼ ΔH−TΔS ¼ −RT lnK ð6Þ
The values of ΔH and ΔS were obtained from the slope
(−ΔH /R , R is the gas constant) and intercept (ΔS /R). The
values ofΔH ,ΔS andΔG at different temperature are given
in Table 2. The negative values of ΔG revealed that the
interaction processes was spontaneous, and the positive ΔH
and ΔS values associated indicated that the hydrophobic
interaction played a major role [24].
Effect of Ionic Strength on the Spectrum of ADNRT-ctDNA
In order to prove the binding mode of ADNRT with ctDNA,
the effect of different concentrations of NaCl (from 0 to
0.25 mol L−1) on the fluorescence of ADNRT-ctDNA system
Table 1 Stern-Volmer quenching
constants for the interaction of
ADNRTwith ctDNA at different
temperatures
T(K) Stern-Volmer equation KSV(L · mol
−1) Kq(L · mol
−1 · s−1) R
298 Y=1.0002+2.209×104[DNA] 2.209×104 2.209×1012 0.9982
304 Y=0.9915+1.809×104[DNA] 1.809×104 1.809×1012 0.9980
310 Y=0.9899+1.389×104[DNA] 1.389×104 1.389×1012 0.9979
Table 2 The binding constants,
number of binding sites and ther-
modynamic parameters of the in-
teraction of ADNRTwith ctDNA
at different temperatures
T(K) K(L · mol−1) n R ΔG(kJ · mol−1) ΔH(kJ · mol−1) ΔS(J · mol−1 · K−1)
295 1.319×104 0.953 0.9972 −23.616
303 3.980×104 1.076 0.9987 −25.911 61.020 286.900
310 4.273×104 1.108 0.9972 −27.919
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and free compound was investigated. It represented that the
fluorescence intensity was not dependent on ionic strength.
When NaCl exists in the system, the electrostatic repulsion
between the negatively charged phosphate skeletons on adja-
cent nucleotides is reduced with the increasing concentration
of Na+ [25]. Apparently, the groove bound molecules can be
released from the helix by increasing the ionic strength,
whereas it is difficult for the intercalation bound molecules
to be released, owing that a small molecule binding in the
groove of DNA duplex exposes much more to the solvent
surrounding than it does for the intercalation [26]. As seen
from Fig. 4, the results demonstrated that the effect of ionic
strength on the ADNRT–ctDNA system was very limited, so
the interaction between ADNRT and ctDNAwas intercalative
binding.
Iodide Quenching Studies
Fluorescence quenching is a reliablemethod to study the binding
of small molecules to DNA. A highly negatively charged
quencher such as I- ion is expected to be repelled by the nega-
tively charged phosphate backbone of DNA [27, 28]. Therefore,
the molecules buried by intercalating into the helix will be
protected from being quenched by I-, while the free aqueous
complex and groove binding molecule should be quenched
readily [9]. Figure 5a depicts the Stern-Volmer plots of the free
ADNRT and the ADNRT-ctDNA system in the presence of KI.
The values of KSV for free ADNRT and the ADNRT-ctDNA
systemwere 419.23 Lmol−1 and 303.85 Lmol−1, respectively. It
was obvious that the quenching effect for free ADNRT was
stronger than that of the bound ADNRT, suggesting that an
intercalation binding should be the interaction mode of
ADNRTwith ctDNA [29].
Comparison of the Interaction of ADNRTwith dsDNA
and ssDNA
The behaviors of native DNA and denatured DNA were
compared. Double-strand DNA was converted into single-
strand DNAwith the opening of its double helix by incubation
at 100 °C for 30 min followed by rapid cooling in ice water
[30]. Generally, thermal denaturation involves the rupture of
hydrogen bonds and no covalent bonds are expected to be
broken. If the interaction between ADNRT and DNA
belonged to a groove binding mode, the extent of the fluores-
cence quenching of ADNRT would be stronger by ssDNA
than that by dsDNA [31]. The results of the comparison
experiments are given in Fig. 5b. The fluorescence quenching
of ADNRT by ssDNAwas smaller than that by dsDNA,which
also supported that ADNRT intercalated into the helix
stack.
Fig. 4 Effect of ionic strength on the fluorescence intensity of ADNRT
and ADNRT-ctDNA system. CADNRT=0.1×10
−6 mol · L−1; CctDNA=
9.1×10−6 mol · L−1; CNaCl=0.01, 0.02, 0.03, 0.04, 0.05, 0.10, 0.15,
0.20, 0.25 mol · L−1
Fig. 5 a Fluorescence quenching
plots of ADNRT by KI in the
absence and presence of ctDNA.
CctDNA=9.2×10
−6 mol · L−1,
CADNRT=3.3×10
−6 mol · L−1; b
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Viscosity Measurements
Optical photophysical studies provide necessary but not suffi-
cient clues to explain a binding between DNA and the com-
plex, while hydrodynamic measurements that are sensitive to
the length change are regarded as the least ambiguous tests of a
binding model in solution [32]. Thus, viscosity measurements
were carried out as an effective tool to further clarify the
binding mode of ADNRT to ctDNA. An intercalator is gener-
ally known to cause a significant increase in the viscosity of a
DNA solution due to lengthen the DNA helix as base pairs are
separated to accommodate the binding ligand [33]. In contrast,
a partial, non-classical ligand intercalation in grooves causes a
bend in DNA helix reducing its effective length and thereby its
viscosity [34]. As illustrated in Fig. 6, the relative viscosities of
the ctDNA increased steadily upon the increasing concentra-
tions of ADNRT. Such behavior further confirmed that
ADNRT bound toDNA through an intercalative bindingmode.
Molecular Docking
Molecular docking technique is an attractive scaffold to under-
stand the drug-DNA interactions which can help to design and
discover the rational drug. As shown in Fig. 7, ADNRT was
successively dockedwith DNA duplex of sequence dodecamer
(PDB ID: 425D) to search the optimal energy ranked results
along with preferred orientation of the ligand inside the DNA
groove. It revealed that the chromophore of ADNRTseemed to
be mainly intercalated between guanine and cytosine base
pairs of DNA. In addition, hydrogen bondings were prone to
form between the amino group H of G or, the carbonyl O of C,
and the intercalator. In this case, the hydroxy O ofADNRTwas
at a distance of 2.8 Å from azyl H atom of G10, the hydroxy H
atom was 2.3 Å from the O2 of C15, the carbonyl O atom was
1.9 Å from the N-2 H atom of G10. The results of molecular
modeling indicated that the interaction between ADNRT and
ctDNA was intercalation dominated and hydrogen bonding
forces might play an essential role in the binding. This result
was consistent with the above spectroscopic and viscosity
experiments.
Conclusion
The interaction between ADNRT and ctDNAwas studied by
spectral analysis, viscosity method and molecular docking.
Hypochromic effects in UV and fluorescence spectroscopy
showed that ADNRTcould interact with ctDNA through static
quenching mechanism. The binding constants and the number
of binding sites of ADNRT binding to ctDNAwere measured
at different temperatures and the thermodynamic parameters
were calculated as well. It was found that hydrophobic force
played a significant role in the binding. The intercalative
binding was much more reasonable by taking account of ionic
strength effects, tests for the ability of ADNRT binding with
dsDNA and ssDNA, KI quenching studies, and the viscosity
measurements. The results obtained from molecular docking
corroborated the experimental results obtained from spectro-
scopic investigations. This combination of spectroscopic and
molecular modeling methods were expected to provide im-
portant insight into designing new antiviral anthracyclines.
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Fig. 6 Effect of increasing amount of ADNRTon the relatively viscosity
of ctDNA
Fig. 7 Computational dockingmodel of the binding of ADNRT to ctDNA
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